These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23876211)

  • 21. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
    Saegusa S; Fei Y; Takahashi T; Sumino H; Moriya J; Kawaura K; Yamakawa J; Itoh T; Morimoto S; Nakahashi T; Iwai K; Matsumoto M; Kanda T
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):155-60. PubMed ID: 17484035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency.
    Nakamura T; Kanno Y; Takenaka T; Suzuki H;
    Hypertens Res; 2005 May; 28(5):415-23. PubMed ID: 16156505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
    Alhusban A; Kozak A; Pillai B; Ahmed H; Sayed MA; Johnson MH; Ishrat T; Ergul A; Fagan SC
    PLoS One; 2017; 12(6):e0178867. PubMed ID: 28640888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.
    Okumi M; Kawada N; Ichimaru N; Kitamura H; Abe T; Imamura R; Kojima Y; Kokado Y; Isaka Y; Rakugi H; Nonomura N; Moriyama T; Takahara S
    Clin Exp Nephrol; 2011 Dec; 15(6):907-15. PubMed ID: 21818547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients.
    Furuya R; Odamaki M; Kumagai H; Hishida A
    Blood Purif; 2006; 24(5-6):445-50. PubMed ID: 16940715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose treatment with angiotensin II receptor blocker in patients with hypertension: differential effect of tissue protection versus blood pressure lowering.
    Shargorodsky M; Hass E; Boaz M; Gavish D; Zimlichman R
    Atherosclerosis; 2008 Mar; 197(1):303-10. PubMed ID: 17588581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; Fogari E; D'Angelo A; Cicero AF
    Hypertens Res; 2010 Aug; 33(8):790-5. PubMed ID: 20505674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
    Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
    Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KRH-594, a new angiotensin AT1 receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats.
    Inada Y; Tazawa S; Murakami M; Akahane M
    Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):206-11. PubMed ID: 11207677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system.
    Akasaki T; Ohya Y; Kuroda J; Eto K; Abe I; Sumimoto H; Iida M
    Hypertens Res; 2006 Oct; 29(10):813-20. PubMed ID: 17283869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Sato A; Takagi S; Tsuchiya K; Imaki T; Takano K
    Hypertension; 2002 Jul; 40(1):28-33. PubMed ID: 12105134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
    Suzuki H; Kanno Y;
    Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.